3004471 |
Pharmacogenetics Panel: Psychotropics |
|
pharmacogenetics |
pharmacogenetics, psychotropics |
3006366 |
Pharmacogenetics Panel: Psychotropics, with GeneDose Access |
|
pharmacogenetics |
pharmacogenetics, psychotropics |
3001524 |
Cytochrome P450 Genotyping Panel |
|
Cytochrome P450 |
CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5 |
3004255 |
Cytochrome P450 Genotyping Panel, with GeneDose Access |
|
Cytochrome P450 |
CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP GD |
3004310 |
CYP2B6 |
|
Cytochrome P450 |
2B6, cytochrome p450, bupropion, efavirenz, methadone, nevirapine |
3001508 |
CYP2C19 |
|
Cytochrome P450 |
clopidogrel (Plavix), antidepressants, voriconazole, protein pump inhibitors (PPIs), omeprazole |
3001501 |
CYP2C8, CYP2C9, and CYP2C cluster |
|
Cytochrome P450 |
warfarin, Coumadin, phenytoin, sulfonylureas, glimepiride, gliclazide, glibenclamide, tolbutamide |
3001513 |
CYP2D6 |
|
Cytochrome P450 |
antidepressants, antipscyhotics, atomoxetine, tramadol, codeine, oxycodone, tamoxifen, zuclopenthixol, tropisetron, felcainide, metoprolol, propafenone |
3001518 |
CYP3A4 and CYP3A5 |
|
Cytochrome P450 |
tacrolimus |
0051332 |
UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping |
|
UGT1A1 Gene Analysis |
UGT1A1, Irinotecan, Pharmacogenetics (PGx), Colorectal Cancer |
2012166 |
Dihydropyrimidine Dehydrogenase (DPYD), 3 Variants |
|
|
Dihydropyrimidine Dehydrogenase (DPYD), 3 Variants |
3001541 |
Warfarin Sensitivity (CYP2C9, CYP2C cluster, CYP4F2, VKORC1) Genotyping |
|
|
Warfarin Sensitivity (CYP2C8, CYP2C9, CYP4F2, VKORC1) Genotype |
2008767 |
Opioid Receptor, Mu 1 (OPRM1) Genotyping, 1 Variant |
|
|
Opioid Receptor, Mu 1 (OPRM1) Genotyping, 1 Variant |
2008426 |
SLCO1B1, 1 Variant |
|
|
SLCO1B1, 1 Variant |
2002429 |
HLA-B*5701 Associated Variant Genotyping for Abacavir Sensitivity |
|
HLA-B*5701 (Abacavir Sensitivity) Genotyping |
HLA-B5701, Pharmacogenetics (PGx), HIV Drug Resistance, HIV, Abacavir sensitivity, Ziagene, Abacavir hypersensitivity, ABC HSR |
2012049 |
HLA-B*15:02 Genotyping, Carbamazepine Hypersensitivity |
|
|
HLA-B*15:02 Genotyping, Carbamazepine Hypersensitivity |
3001393 |
HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity |
|
|
HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity |